Abstract
Defensins are a group of antimicrobial peptides (AMPs) found in different living organisms, and are involved in the first line of defense in the innate immune response against pathogens. The increase in the resistance of bacteria to conventional antibiotics and the need for new antibiotics has stimulated interest in the use of AMPs as new therapeutic agents. The inducible nature of human defensin genes suggests that it is possible to increase the endogenous production by utilizing small molecules of various origins to enhance, even selectively, the expression of these peptides. In the light of their role in immunomodulation, angiogenesis, wound healing, inflammation and cancer, as well as their antimicrobial activity, it is possible induce their expression or create analogs with increased specific activity or various degrees of selectivity, or obtain human defensins with genetic engineering to optimize the potency and safety in order to reduce cytotoxicity and potential proinflammatory activity and susceptibility to protease and salt. Restoring the balance between immunostimulating and immunosuppressive molecules may be an important strategy to correct expression defects in specific diseases.
Authors’ Contributions
GD, IP, AB: Prepared and edited the manuscript. AF, BP, EB: Edited the manuscript. All authors added intellectual content, read and approved the final version
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abiko Y, Saitoh M, Nishimura M, Yamazaki M, Sawamura D, Kaku T (2007) Role of beta-defensins in oral epithelial health and disease. Med Mol Morphol 40(4):179–184. doi:10.1007/s00795-007-0381-8
Albani D, Polito L, Signorini A, Forloni G (2010) Neuroprotective properties of resveratrol in different neurodegenerative disorders. Biofactors 36(5):370–376. Review. doi: 10.1002/biof.118
Ashbee HR, Evans EG (2002) Immunology of diseases associated with Malassezia species. Clin Microbiol Rev 15(1):21–57. Review. doi:10.1128/CMR.15.1.21-57.2002
Bajaj-Elliott M, Fedeli P, Smith GV, Domizio P, Maher L, Ali RS, Quinn AG, Farthing MJ (2002) Modulation of host antimicrobial peptide (beta-defensins 1 and 2) expression during gastritis. Gut 51(3):356–361. PMID: 12171956
Balato A, Paoletti I, De Gregorio V, Cantelli M, Ayala F, Donnarumma G (2014) Tacrolimus does not alter the production of several cytokines and antimicrobial peptide in Malassezia furfur-infected-keratinocytes. Mycoses 57(3):176–183. doi:10.1111/myc.12140
Bals R, Wang X, Wu Z, Freeman T, Bafna V, Zasloff M, Wilson JM (1998) Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest 102(5):874–880. PMID:9727055 DOI:10.1172/JCI2410
Baroni A, Perfetto B, Paoletti I, Ruocco E, Canozo N, Orlando M, Buommino E (2001) Malassezia furfur invasiveness in a keratinocyte cell line (HaCat): effects on cytoskeleton and on adhesion molecule and cytokine expression. Arch Dermatol Res 293(8):414–419. PubMed PMID: 11686517
Baroni A, Paoletti I, Silvestri I, Buommino E, Carriero MV (2003) Early vitronectin receptor downregulation in a melanoma cell line during all-trans retinoic acid-induced apoptosis. Br J Dermatol 148(3):424–433. doi:10.1046/j.1365-2133.2003.05165.x
Baroni A, Paoletti I, Ruocco E, Agozzino M, Tufano MA, Donnarumma G (2004) Possible role of Malassezia furfur in psoriasis: modulation of TGF-beta1, integrin, and HSP70 expression in human keratinocytes and in the skin of psoriasis-affected patients. J Cutan Pathol 31(1):35–42. doi:10.1046/j.0303-6987.2004.0135.x
Baroni A, Orlando M, Donnarumma G, Farro P, Iovene MR, Tufano MA, Buommino E (2006) Toll-like receptor 2 (TLR2) mediates intracellular signalling in human keratinocytes in response to Malassezia furfur. Arch Dermatol Res 297(7):280–288. doi:10.1007/s00403-005-0594-4
Baroni A, Brunetti G, Ruocco E (2011) Coexistence of malignancy (skin cancer) and immune disorder (discoid lupus erythematosus) on a burn scar: a concrete example of ‘immunocompromised district’. Br J Dermatol 164(3):673–675. doi:10.1111/j.1365-2133.2010.10170.x
Baroni A, Buommino E, De Gregorio V, Ruocco E, Ruocco V, Wolf R (2012) Structure and function of the epidermis related to barrier properties. Clin Dermatol 30(3):257–262. PMID:22507037. doi:10.1016/j.clindermatol.2011.08.007
Baroni A, Russo T, Piccolo V, Siano M, Russo D, Nacca L, Ruocco E (2013) Opportunistic metastatic porocarcinoma after saphenous venectomy for coronary bypass surgery. Clin Exp Dermatol 38(5):507–510. doi:10.1111/ced.12032
Baroni A, Buommino E, Piccolo V, Chessa MA, Russo T, Cozza V, Ruocco V (2014) Alterations of skin innate immunity in lymphedematous limbs: correlations with opportunistic diseases. Clin Dermatol 32(5):592–598. doi:10.1016/j.clindermatol.2014.04.006
Bastian A, Schäfer H (2001) Human alpha-defensin 1 (HNP-1) inhibits adenoviral infection in vitro. Regul Pept 101(1–3):157–161. doi:10.1016/S0167-0115(01)00282-8
Bauer B, Pang E, Holland C, Kessler M, Bartfeld S, Meyer TF (2012) The Helicobacter pylori virulence effector CagA abrogates human β-defensin 3 expression via inactivation of EGFR signaling. Cell Host Microbe 11(6):576–586. doi:10.1016/j.chom.2012.04.013
Becker MN, Diamond G, Verghese MW, Randell SH (2000) CD14-dependentlipopolysaccharide-induced beta-defensin-2 expression in human tracheobronchial epithelium. J Biol Chem 275(38):29731–29736. doi:10.1074/jbc.M000184200
Bevins CL (2006) Paneth cell defensins: key effector molecules of innate immunity. Biochem Soc Trans 34(Pt 2):263–266. Review. doi:10.1042/BST20060263
Breitkreutz D, Mirancea N, Nischt R (2009) Basement membranes in skin: unique matrix structures with diverse functions? Histochem Cell Biol 132(1):1–10. PMID:19333614. doi:10.1007/s00418-009-0586-0
Buommino E, De Filippis A, Parisi A, Nizza S, Martano M, Iovane G, Donnarumma G, Tufano MA, De Martino L (2013) Innate immune response in human keratinocytes infected by a feline isolate of Malassezia pachydermatis. Vet Microbiol 63(1–2):90–96. doi:10.1016/j.vetmic.2012.12.001
Buommino E, Di Domenico M, Paoletti I, Fusco A, De Gregorio V, Cozza V, Rizzo A, Tufano MA, Donnarumma G (2014) Alpha(v)beta5 integrins mediates Pseudomonas fluorescens interaction with A549 cells. Front Biosci (Landmark Ed) 19:408–415
Butmarc J, Yufit T, Carson P, Falanga V (2004) Human beta-defensin-2 expression is increased in chronic wounds. Wound Repair Regen 12(4):439–443. PMID: 15260809. doi:10.1111/j.1067-1927.2004.12405.x
Carothers DG, Graham SM, Jia HP, Ackermann MR, Tack BF, McCray PB Jr (2001) Production of beta-defensin antimicrobial peptides by maxillary sinus mucosa. Am J Rhinol 15(3):175–179. PMID: 11453504 DOI.org/10.2500/105065801779954238
Chapalain A, Rossignol G, Lesouhaitier O, Merieau A, Gruffaz C, Guerillon J, Meyer JM, Orange N, Feuilloley MG (2008) Comparative study of 7 fluorescent pseudomonad clinical isolates. Can J Microbiol 54(1):19–27. doi:10.1139/w07-110
Christophers E, Henseler T (1987) Contrasting disease patterns in psoriasis and atopic dermatitis. Arch Dermatol Res 279(Suppl):S48–S51. PubMed PMID: 3662604
Clavaud C, Jourdain R, Bar-Hen A, Tichit M, Bouchier C, Pouradier F, El Rawadi C, Guillot J, Ménard-Szczebara F, Breton L, Latgé JP, Mouyna I (2013) Dandruff is associated with disequilibrium in the proportion of the major bacterial and fungal populations colonizing the scalp. PLoS ONE 8(3):e58203. doi:10.1371/annotation/bcff4a59-10b7-442a-8181-12fa69209e57
Corrales-Garcia LL, Possani LD, Corzo G (2011) Expression systems of human β-defensins: vectors, purification and biological activities. Amino Acids 40(1):5–13. PMID: 20306097. doi:10.1007/s00726-010-0493-7
Cover TL, Blaser MJ (2009) Helicobacter pylori in health and disease. Gastroenterology 136(6):1863–1873. doi:10.1053/j.gastro.2009.01.073
Crouch Brewer S, Wunderink RG, Jones CB, Leeper KV Jr (1996) Ventilator-associated pneumonia due to Pseudomonas aeruginosa. Chest 109(4):1019–1029. doi:10.1378/chest.109.4.1019
Dale BA, Krisanaprakornkit S (2001) Defensin antimicrobial peptides in the oral cavity. J Oral Pathol Med 30(6):321–332. PMID:11459317. doi:10.1034/j.1600-0714.2001.300601.x
Darveau RP, Cunningham MD, Seachord CL, Cassiano-Clough L, Cosand WL, Blake J, Watkins CS (1991) Beta-lactam antibiotics potentiate magainin 2 antimicrobial activity in vitro and in vivo. Antimicrob Agents Chemother 35(6):1153–1159. doi:10.1128/AAC.35.6.1153
De Luca M, Pellegrini G, Zambruno G, Marchisio PC (1994) Role of integrins in cell adhesion and polarity in normal keratinocytes and human skin pathologies. J Dermatol 21(11):821–828. PubMed PMID: 7852642, Review
Do Monte FH, dos Santos JG Jr, Russi M, Lanziotti VM, Leal LK, Cunha GM (2004) Antinociceptive and anti-inflammatory properties of the hydroalcoholic extract of stems from Equisetum arvense in mice. Pharmacol Res 49(3):239–243. doi:10.1016/j.phrs.2003.10.002
Donnarumma G, Paoletti I, Buommino E, Orlando M, Tufano MA, Baroni A (2004) Malassezia furfur induces the expression of beta-defensin-2 in human keratinocytes in a protein kinase C-dependent manner. Arch Dermatol Res 295(11):474–481. doi:10.1007/s00403-003-0445-0
Donnarumma G, Buommino E, Baroni A, Auricchio L, De Filippis A, Cozza V, Msika P, Piccardi N, Tufano MA (2007a) Effects of AV119, a natural sugar from avocado, on Malassezia furfur invasiveness and on the expression of HBD-2 and cytokines in human keratinocytes. Exp Dermatol 16(11):912–919. doi:10.1111/j.1600-0625.2007.00613.x
Donnarumma G, Paoletti I, Buommino E, Iovene MR, Tudisco L, Cozza V, Tufano MA (2007b) Anti-inflammatory effects of moxifloxacin and human beta-defensin 2 association in human lung epithelial cell line (A549) stimulated with lipopolysaccharide. Peptides 28(12):2286–2292. doi:10.1016/j.peptides.2007.09.009
Donnarumma G, Buommino E, Fusco A, Paoletti I, Auricchio L, Tufano MA (2010) Effect of temperature on the shift of Pseudomonas fluorescens from an environmental microorganism to a potential human pathogen. Int J Immunopathol Pharmacol 23(1):227–234. PMID:20378008
Donnarumma G, Perfetto B, Paoletti I, Oliviero G, Clavaud C, Del Bufalo A, Guéniche A, Jourdain R, Tufano MA, Breton L (2014a) Analysis of the response of humankeratinocytes to Malassezia globosa and restricta strains. Arch Dermatol Res 306(8):763–768. doi:10.1007/s00403-014-1479-1
Donnarumma G, Molinaro A, Cimini D, De Castro C, Valli V, De Gregorio V, De Rosa M, Schiraldi C (2014b) Lactobacillus crispatus L1: high cell density cultivation and exopolysaccharide structure characterization to highlight potentially beneficial effects against vaginal pathogens. BMC Microbiol 14:137. doi:10.1186/1471-2180-14-137
Dorozynski A (1997) Wine may prevent dementia. BMJ 314(7086):997. PMID: 9112841
Dunsche A, Açil Y, Dommisch H, Siebert R, Schröder JM, Jepsen S (2002) The novel human beta-defensin-3 is widely expressed in oral tissues. Eur J Oral Sci 110(2):121–124. PMID: 12013554. doi:10.1034/j.1600-0722.2002.11186.x
Eckert R, Qi F, Yarbrough DK, He J, Anderson MH, Shi W (2006) Adding selectivity to antimicrobial peptides: rational design of a multidomain peptide against Pseudomonas spp. Antimicrob Agents Chemother 50(4):1480–1488. PMID:16569868. doi:10.1128/AAC.50.4.1480-1488.2006
Estrada G, Garcia BI, Schiavon E, Ortiz E, Cestele S, Wanke E, Possani LD, Corzo G (2007) Four disulfide-bridged scorpion beta neurotoxin CssII: heterologous expression and proper folding in vitro. Biochim Biophys Acta 1770(8):1161–1168. doi:10.1016/j.bbagen.2007.04.006
Fattorini L, Gennaro R, Zanetti M, Tan D, Brunori L, Giannoni F, Pardini M, Orefici G (2004) In vitro activity of protegrin-1 and beta-defensin-1, alone and in combination with isoniazid, against Mycobacterium tuberculosis. Peptides 25(7):1075–1077. doi:10.1016/j.peptides.2004.04.003
Fehlbaum P, Rao M, Zasloff M, Anderson GM (2000) An essential amino acid induces epithelial beta -defensin expression. Proc Natl Acad Sci U S A 97(23):12723–12728. doi:10.1073/pnas.220424597
Frankel EN, Waterhouse AL, Kinsella JE (1993) Inhibition of human LDL oxidation by resveratrol. Lancet 341:1103–1104. doi:10.1016/0140-6736(93)92472-6
George JT, Boughan PK, Karageorgiou H, Bajaj-Elliott M (2003) Host anti-microbial response to Helicobacter pylori infection. Mol Immunol 40(7):451–456. doi:10.1016/S0161-5890(03)00158-5
Gershman MD, Kennedy DJ, Noble-Wang J, Kim C, Gullion J, Kacica M, Jensen B, Pascoe N, Saiman L, McHale J, Wilkins M, Schoonmaker-Bopp D, Clayton J, Arduino M, Srinivasan A (2008) Pseudomonas fluorescens Investigation Team. Multistate outbreak of Pseudomonas fluorescens bloodstream infection after exposure to contaminated heparinized saline flush prepared by a compounding pharmacy. Clin Infect Dis 47(11):1372–1379. doi:10.1086/592968
Giacometti A, Cirioni O, Ghiselli R, Mocchegiani F, Del Prete MS, Viticchi C, Kamysz W, ŁEmpicka E, Saba V, Scalise G (2002) Potential therapeutic role of cationic peptides in three experimental models of septic shock. Antimicrob Agents Chemother 46(7):2132–2136. doi:10.1128/AAC.46.7.2132-2136.2002
Goldman MJ, Anderson GM, Stolzenberg ED, Kari UP, Zasloff M, Wilson JM (1997) Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88(4):553–560. doi:10.1016/S0092-8674(00)81895-4
Grether-Beck S, Felsner I, Brenden H, Kohne Z, Majora M, Marini A, Jaenicke T, Rodriguez-Martin M, Trullas C, Hupe M, Elias PM, Krutmann J (2012) Urea uptake enhances barrier function and antimicrobial defense in humans by regulating epidermal gene expression. J Invest Dermatol 132(6):1561–1572. doi:10.1038/jid.2012.42
Grossman RM, Krueger J, Yourish D, Granelli-Piperno A, Murphy DP, May LT, Kupper TS, Sehgal PB, Gottlieb AB (1989) Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci U S A 86(16):6367–6371. PubMed PMID: 2474833
Grubman A, Kaparakis M, Viala J, Allison C, Badea L, Karrar A, Boneca IG, Le Bourhis L, Reeve S, Smith IA, Hartland EL, Philpott DJ, Ferrero RL (2010) The innate immune molecule, NOD1, regulates direct killing of Helicobacter pylori by antimicrobial peptides. Cell Microbiol 12(5):626–639. doi:10.1111/j.1462-5822.2009.01421.x
Hamanaka Y, Nakashima M, Wada A, Ito M, Kurazono H, Hojo H, Nakahara Y, Kohno S, Hirayama T, Sekine I (2001) Expression of human beta-defensin 2 (hBD-2) in Helicobacter pylori induced gastritis: antibacterial effect of hBD-2 against Helicobacter pylori. Gut 49(4):481–487. PubMed PMID: 11559643
Hancock RE, Sahl HG (2000) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24(12):1551–1557. Review. doi:10.1038/nbt1267
Harder J, Bartels J, Christophers E, Schröder JM (1997) A peptide antibiotic from human skin. Nature 387(6636):861. PubMed PMID: 9202117
Harder J, Meyer-Hoffert U, Teran LM, Schwichtenberg L, Bartels J, Maune S, Schröder JM (2000) Mucoid Pseudomonas aeruginosa, TNF-alpha, and IL-1beta, but not IL-6, induce human beta-defensin-2 in respiratory epithelia. Am J Respir Cell Mol Biol 22(6):714–721. PMID:10837369. doi:10.1165/ajrcmb.22.6.4023
Harder J, Bartels J, Christophers E, Schroder JM (2001) Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 276(8):5707–5713. PMID:11085990. doi:10.1074/jbc.M008557200
Harder J, Meyer-Hoffert U, Wehkamp K, Schwichtenberg L, Schröder JM (2004) Differential gene induction of human beta-defensins (hBD-1, -2, -3, and -4) in keratinocytes is inhibited by retinoic acid. J Invest Dermatol 123(3):522–529. PMID:15304092. doi:10.1111/j.0022-202X.2004.23234.x
Hiratsuka T, Nakazato M, Ihi T, Minematsu T, Chino N, Nakanishi T, Shimizu A, Kangawa K, Matsukura S (2000) Structural analysis of human beta-defensin-1 and its significance in urinary tract infection. Nephron 85(1):34–40. doi:10.1159/000045627
Hollox EJ, Huffmeier U, Zeeuwen PL, Palla R, Lascorz J, Rodijk-Olthuis D, van de Kerkhof PC, Traupe H, de Jongh G, den Heijer M, Reis A, Armour JA, Schalkwijk J (2008) Psoriasis is associated with increased beta-defensin genomic copy number. Nat Genet 40(1):23–25. doi:10.4049/jimmunol.171.6.3262
Hooper DC, Wolfson JS (1991) Fluoroquinolone antimicrobial agents. N Engl J Med 324(6):384–394. Review. doi:10.1056/NEJM199102073240606
Hornsby MJ, Huff JL, Kays RJ, Canfield DR, Bevins CL, Solnick JV (2008) Helicobacter pylori induces an antimicrobial response in rhesus macaques in a cag pathogenicity island-dependent manner. Gastroenterology 134(4):1049–1057. doi:10.1053/j.gastro.2008.01.018
Hostanska K, Melzer J, Amon A, Saller R (2011) Suppression of interleukin (IL)-8 and human beta defensin-2 secretion in LPS-and/or IL-1β-stimulated airway epithelial A549 cells by a herbal formulation against respiratory infections (BNO 1030). J Ethnopharmacol 134(2):228–233. doi:10.1016/j.jep.2010.12.006
Howell MD, Novak N, Bieber T, Pastore S, Girolomoni G, Boguniewicz M, Streib J, Wong C, Gallo RL, Leung DY (2005) Interleukin-10 downregulates anti-microbial peptide expression in atopic dermatitis. J Invest Dermatol 125(4):738–745. doi:10.1111/j.0022-202X.2005.23776.x
Howell MD, Boguniewicz M, Pastore S, Novak N, Bieber T, Girolomoni G, Leung DY (2006) Mechanism of HBD-3 deficiency in atopic dermatitis. Clin Immunol 121(3):332–338. doi:10.1016/j.clim.2006.08.008
Hu X, Bidney DL, Yalpani N, Duvick JP, Crasta O, Folkerts O, Lu G (2003) Overexpression of a gene encoding hydrogen peroxide-generating oxalate oxidase evokes defense responses in sunflower. Plant Physiol 133(1):170–181. doi:10.1104/pp.103.024026
Jainkittivong A, Johnson DA, Yeh CK (1998) The relationship between salivary histatin levels and oral yeast carriage. Oral Microbiol Immunol 13(3):181–187. doi:10.1111/j.1399-302X.1998.tb00730.x
Kao CY, Chen Y, Thai P, Wachi S, Huang F, Kim C, Harper RW, Wu R (2004) IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways. J Immunol 173(5):3482–3491. doi:10.4049/jimmunol.173.5.3482
Kim ST, Cha HE, Kim DY, Han GC, Chung YS, Lee YJ, Hwang YJ, Lee HM (2003) Antimicrobial peptide LL-37 is upregulated in chronic nasal inflammatory disease. Acta Otolaryngol 123(1):81–85. doi:10.1080/0036554021000028089
King AE, Fleming DC, Critchley HO, Kelly RW (2002) Regulation of natural antibiotic expression by inflammatory mediators and mimics of infection in human endometrial epithelial cells. Mol Hum Reprod 8(4):341–349. doi:10.1093/molehr/8.4.341
Kutta H, Steven P, Kohla G, Tillmann B, Paulsen F (2002) The human false vocal folds an analysis of antimicrobial defense mechanisms. Anat Embryol Berl 205(4):315–323. doi:10.1007/s00429-002-0255-8
Lai Y, Cogen AL, Radek KA, Park HJ, Macleod DT, Leichtle A, Ryan AF, Di Nardo A, Gallo RL (2010) Activation of TLR2 by a small molecule produced by Staphylococcus epidermidis increases antimicrobial defense against bacterial skin infections. J Invest Dermatol 130(9):2211–2221. PMID:21085191. doi:10.1038/jid.2010.123
Lanzilli G, Cottarelli A, Nicotera G, Guida S, Ravagnan G, Fuggetta MP (2012) Anti-inflammatory effect of resveratrol and polydatin by in vitro IL-17 modulation. Inflammation 35(1):240–248. doi:10.1007/s10753-011-9310-z
Lee SH, Kim JE, Lim HH, Lee HM, Choi JO (2002) Antimicrobial defensin peptides of the human nasal mucosa. Ann Otol Rhinol Laryngol 111(2):135–141. doi:10.1177/000348940211100205
Lehmann J, Retz M, Harder J, Krams M, Kellner U, Hartmann J, Hohgräwe K, Raffenberg U, Gerber M, Loch T, Weichert-Jacobsen K, Stöckle M (2002) Expression of human beta-defensins 1 and 2 in kidneys with chronic bacterial infection. BMC Infect Dis 18:2. doi:10.1186/1471-2334-2-20
Lieberman D (2003) Pseudomonal infections in patients with COPD: epidemiology and management. Am J Respir Med 2(6):459–468. Review. doi:10.1007/BF03256673
Liu AY, Destoumieux D, Wong AV, Park CH, Valore EV, Liu L, Ganz T (2002) Human beta-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation. J Invest Dermatol 118(2):275–281. PMID: 11841544 DOI:10.1046/j.0022-202x.2001.01651.x
Liu L, Roberts AA, Ganz T (2003) By IL-1 signaling, monocyte-derived cells dramatically enhance the epidermal antimicrobial response to lipopolysaccharide. J Immunol 170(1):575–580. PMID:12496445. doi:10.4049/jimmunol.170.1.575
Liu LL, Yang JL, Shi YP (2010) Phytochemicals and biological activities of Pulicaria species. Chem Biodivers 7(2):327–349. doi:10.1080/10286020903496455
Liu Y, Chan F, Sun H, Yan J, Fan D, Zhao D, An J, Zhou D (2011) Resveratrol protects human keratinocytes HaCaT cells from UVA-induced oxidative stress damage by downregulating Keap1 expression. Eur J Pharmacol 650(1):130–137. doi:10.1016/j.ejphar.2010.10.009
MacRedmond R, Greene C, Taggart CC, McElvaney N, O’Neill S (2005) Respiratory epithelial cells require Toll-like receptor 4 for induction of human beta-defensin 2 by lipopolysaccharide. Respir Res 6:116. doi:10.1186/1465-9921-6-116
MacRedmond RE, Greene CM, Dorscheid DR, McElvaney NG, O’Neill SJ (2007) Epithelial expression of TLR4 is modulated in COPD and by steroids, salmeterol and cigarette smoke. Respir Res 8:84. doi:10.1186/1465-9921-8-84
Maisetta G, Batoni G, Esin S, Luperini F, Pardini M, Bottai D, Florio W, Giuca MR, Gabriele M, Campa M (2003) Activity of human beta-defensin 3 alone or combined with other antimicrobial agents against oral bacterial. Antimicrob Agents Chemother 47(10):3349–3351. PMID: 14506056. doi:10.1128/AAC.47.10.3349-3351.2003
Marr AK, Gooderham WJ, Hancock RE (2006) Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr Opin Pharmacol 6(5):468–472. Review. doi:10.1016/j.coph.2006.04.006
McDermott AM, Redfern RL, Zhang B, Pei Y, Huang L, Proske RJ (2003) Defensin expression by the cornea: multiple signalling pathways mediate IL-1beta stimulation of hBD-2 expression by human corneal epithelial cells. Invest Ophthalmol Vis Sci 44(5):1859–1865. PMID: 12714616. doi:10.1167/iovs.02-0787
Nakajima K, Terao M, Takaishi M, Kataoka S, Goto-Inoue N, Setou M, Horie K, Sakamoto F, Ito M, Azukizawa H, Kitaba S, Murota H, Itami S, Katayama I, Takeda J, Sano S (2013) Barrier abnormality due to ceramide deficiency leads to psoriasiform inflammation in a mouse model. J Invest Dermatol 133(11):2555–2565. doi:10.1038/jid.2013.199
Niyonsaba F, Someya A, Hirata M, Ogawa H, Nagaoka I (2001) Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells. Eur J Immunol 31(4):1066–1075. doi:10.1002/1521-4141(200104). PMID: 11298331. doi:10.1002/1521-4141(200104)
Niyonsaba F, Ogawa H, Nagaoka I (2004) Human beta-defensin-2 functions as a chemotactic agent for tumour necrosis factor-alpha-treated human neutrophils. Immunology 111(3):273–281. doi:10.1111/j.0019-2805.2004.01816.xPMID:15009427
Nomura I, Goleva E, Howell MD, Hamid QA, Ong PY, Hall CF, Darst MA, Gao B, Boguniewicz M, Travers JB, Leung DY (2003) Cytokine Milieu of Atopic Dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 171(6):3262–3269. doi:10.4049/jimmunol.171.6.3262
Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Gallo RL, Leung DY (2002) Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347(15):1151–1160. doi:10.1056/NEJMoa021481
Paoletti I, Buommino E, Tudisco L, Baudouin C, Msika P, Tufano MA, Baroni A, Donnarumma G (2010) Patented natural avocado sugars modulate the HBD-2 expression in human keratinocytes through the involvement of protein kinase C and protein tyrosine kinases. Arch Dermatol Res 302(3):201–209. doi:10.1007/s00403-009-0991-1
Paoletti I, Buommino E, Fusco A, Baudouin C, Msika P, Tufano MA, Baroni A, Donnarumma G (2012) Patented natural avocado sugar modulates the HBD-2 and HBD-3 expression in human keratinocytes through toll-like receptor-2 and ERK/MAPK activation. Arch Dermatol Res 304(8):619–625. doi:10.1007/s00403-012-1237-1
Pazgier M, Hoover DM, Yang D, Lu W, Lubkowski J (2006) Human beta-defensins. Cell Mol Life Sci 63(11):1294–1313. Review PMID:16710608. doi:10.1007/s00018-005-5540-2
Pechkovsky DV, Zissel G, Ziegenhagen MW, Einhaus M, Taube C, Rabe KF, Magnussen H, Papadopoulos T, Schlaak M, Müller-Quernheim J (2000) Effect of proinflammatory cytokines on interleukin-8 mRNA expression and protein production by isolated human alveolar epithelial cells type II in primary culture. Eur Cytokine Netw 11(4):618–625. PMID: 11125305
Poiraud C, Quereux G, Knol AC, Zuliani T, Allix R, Khammari A, Dreno B (2012) Human β defensin-2 and psoriasin, two new innate immunity targets of zinc gluconate. Eur J Dermatol 22(5):634–639. doi:10.1684/ejd.2012.1800
Prado-Montes de Oca E, García-Vargas A, Lozano-Inocencio R, Gallegos-Arreola MP, Sandoval-Ramírez L, Dávalos-Rodríguez NO, Figuera LE (2007) Association of beta-defensin 1 single nucleotide polymorphisms with atopic dermatitis. Int Arch Allergy Immunol 142(3):211–218. PMID:17108702 DOI:10.1159/000097023
Prohic A, Kasumagic-Halilovic E (2009) Identification of Malassezia pachydermatis from healthy and diseased human skin. Med Arh 63(6):317–319. doi:10.1007/s00403-014-1479-1
Proksch E, Brandner JM, Jensen JM (2008) The skin: an indispensable barrier. Exp Dermatol 7(12):1063–1072. Review PMID: 19043850. doi:10.1111/j.1600-0625.2008.00786.x
Proud D, Sanders SP, Wiehler S (2004) Human rhinovirus infection induces airway epithelial cell production of human beta-defensin 2 both in vitro and in vivo. J Immunol 172(7):4637–4645. doi:10.4049/jimmunol.172.7.4637
Quiñones-Mateu ME, Lederman MM, Feng Z, Chakraborty B, Weber J, Rangel HR, Marotta ML, Mirza M, Jiang B, Kiser P, Medvik K, Sieg SF, Weinberg A (2003) Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication. AIDS 17(16):F39–F48. doi:10.1097/01.aids.0000096878.73209.4f
Radek K, Gallo R (2007) Antimicrobial peptides: natural effectors of the innate immune system. Semin Immunopathol 29(1):27–43. Review PMID:17621952. doi:10.1007/s00281-007-0064-5
Rolli M, Fransvea E, Pilch J, Saven A, Felding-Habermann B (2003) Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells. Proc Natl Acad Sci U S A 100(16):9482–9487. PMID: 12874388
Ryan CA, Kimber I, Basketter DA, Pallardy M, Gildea LA, Gerberick GF (2007) Dendritic cells and skin sensitization: biological roles and uses in hazard identification. Toxicol Appl Pharmacol 221(3):384–394. Review. doi:10.1016/j.taap.2007.03.006
Sanford JA, Gallo RL (2013) Functions of the skin microbiota in health and disease. Semin Immunol 25(5):370–377. PMID: 24268438. doi:10.1016/j.smim.2013.09.005
Sass V, Schneider T, Wilmes M, Körner C, Tossi A, Novikova N, Shamova O, Sahl HG (2010) Human beta-defensin 3 inhibits cell wall biosynthesis in Staphylococci. Infect Immun 78(6):2793–2800. doi:10.1128/IAI.00688-09
Schaller-Bals S, Schulze A, Bals R (2002) Increased levels of antimicrobial peptides in tracheal aspirates of newborn infants during infection. Am J Respir Crit Care Med 165(7):992–995. doi:10.1164/ajrccm.165.7.200110-020
Schutte BC, McCray PB Jr (2002) [beta]-defensins in lung host defense. Annu Rev Physiol 64:709–748. Review. doi:10.1146/annurev.physiol.64.081501.134340
Scola N, Gambichler T, Saklaoui H, Bechara FG, Georgas D, Stücker M, Gläser R, Kreuter A (2012) The expression of antimicrobial peptides is significantly altered in cutaneous squamous cell carcinoma and precursor lesions. Br J Dermatol 167(3):591–597. doi:10.1111/j.1365-2133.2012.11110.x
Shanahan F (2002) Probiotics and inflammatory bowel disease: from fads and fantasy to facts and future. Br J Nutr 88(Suppl 1):S5–S9. PMID:12215176
Sharma S, Verma I, Khuller GK (2000) Antibacterial activity of human neutrophil peptide-1 against Mycobacterium tuberculosis H37Rv: in vitro and ex vivo study. Eur Respir J 16(1):112–117. PMID: 10933095
Signat B, Roques C, Poulet P, Duffaut D (2011) Fusobacterium nucleatum in periodontal health and disease. Curr Issues Mol Biol 13(2):25–36. PMID: 21220789
Sinha S, Cheshenko N, Lehrer RI, Herold BC (2003) NP-1, a rabbit alpha-defensin, prevents the entry and intercellular spread of herpes simplex virus type 2. Antimicrob Agents Chemother 47(2):494–500. doi:10.1128/AAC.47.2.494-500.2003
Situ H, Balasubramanian SV, Bobek LA (2000) Role of alpha-helical conformation of histatin-5 in candidacidal activity examined by proline variants. Biochim Biophys Acta 1475(3):377–382. doi:10.1016/S0304-4165(00)00096-9
Smith JJ, Travis SM, Greenberg EP, Welsh MJ (1996) Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85(2):229–236. doi:10.1016/S0092-8674(00)81099-5
Sørensen OE, Thapa DR, Roupé KM, Valore EV, Sjöbring U, Roberts AA, Schmidtchen A, Ganz T (2006) Injury-induced innate immune response in human skin mediated by transactivation of the epidermal growth factor receptor. J Clin Invest 116(7):1878–1885. doi:10.1172/JCI28422. PMID: 16778986
Stevens DL (1996) Immune modulatory effects of antibiotics. Curr Opin Infect Dis 46:98–102
Svanborg C, Godaly G, Hedlund M (1999) Cytokine responses during mucosal infections: role in disease pathogenesis and host defence. Curr Opin Microbiol 2(1):99–105. Review PMID:10047563. doi:10.1016/S0952-7915(00)00187-4
Travis SM, Singh PK, Welsh MJ (2001) Antimicrobial peptides and proteins in the innate defense of the airway surface. Curr Opin Immunol 13(1):89–95. Review PMID:11154923 DOI:10.1016/S0952-7915(00)00187-4
Tsai H, Bobek LA (1998) Human salivary histatins: promising anti-fungal therapeutic agents. Crit Rev Oral Biol Med 9(4):480–497. doi:10.1177/10454411980090040601
Tsutsumi-Ishii Y, Nagaoka I (2003) Modulation of human beta-defensin-2 transcription in pulmonary epithelial cells by lipopolysaccharide-stimulated mononuclear phagocytes via proinflammatory cytokine production. J Immunol 170(8):4226–4236. doi:10.4049/jimmunol.170.8.4226
Uehara N, Yagihashi A, Kondoh K, Tsuji N, Fujita T, Hamada H, Watanabe N (2003) Human beta-defensin-2 induction in Helicobacter pylori-infected gastric mucosal tissues: antimicrobial effect of overexpression. J Med Microbiol 52(Pt 1):41–45. doi:10.1099/jmm.0.04985-
Valore EV, Park CH, Quayle AJ, Wiles KR, McCray PB Jr, Ganz T (1998) Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J Clin Invest 101(8):1633–1642. doi:10.1172/JCI1861
van’t Hof W, Reijnders IM, Helmerhorst EJ, Walgreen-Weterings E, Simoons-Smit IM, Veerman EC, Amerongen AV (2000) Synergistic effects of low doses of histatin 5 and its analogues on amphotericin B anti-mycotic activity. Antonie Van Leeuwenhoek 78(2):163–169. PubMed. doi:10.1023/A:1026572128004
VanderSpek JC, Wyandt HE, Skare JC, Milunsky A, Oppenheim FG, Troxler RF (1989) Localization of the genes for histatins to human chromosome 4q13 and tissue distribution of the mRNAs. Am J Hum Genet 45(3):381–387. PMID: 2773933
Wanke I, Steffen H, Christ C, Krismer B, Götz F, Peschel A, Schaller M, Schittek B (2011) Skin commensals amplify the innate immune response to pathogens by activation of distinct signaling pathways. J Invest Dermatol 131(2):382–390. PMID:21048787. doi:10.1038/jid.2010.328
Watanabe S, Kano R, Sato H, Nakamura Y, Hasegawa A (2001) The effects of Malassezia yeasts on cytokine production by human keratinocytes. J Invest Dermatol 116(5):769–773. doi:10.1046/j.1523-1747.2001.01321.x
Wehkamp J, Fellermann K, Herrlinger KR, Baxmann S, Schmidt K, Schwind B, Duchrow M, Wohlschläger C, Feller AC, Stange EF (2002) Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease. Eur J Gastroenterol Hepatol 14(7):745–752. PMID:12169983
Whitsett JA (2002) Intrinsic and innate defenses in the lung: intersection of pathways regulating lung morphogenesis, host defense, and repair. J Clin Invest 109(5):565–569. Review. doi:10.1172/JCI15209
Wiechuła BE, Friedek DA, Ekiel AM, Romanik MK, Martirosian G (2007) Human neutrophil peptides in vaginitis/cervicitis of different etiology. Pol J Microbiol 56(3):185–189. PMID: 18062652
Yamaguchi Y, Nagase T, Makita R, Fukuhara S, Tomita T, Tominaga T, Kurihara H, Ouchi Y (2002) Identification of multiple novel epididymis-specific beta-defensin isoforms in humans and mice. J Immunol 169(5):2516–2523. doi:10.4049/jimmunol.169.5.2516
Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, Anderson M, Schröder JM, Wang JM, Howard OM, Oppenheim JJ (1999) Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286(5439):525–528. PMID: 10521347. doi:10.1126/science.286.5439.525
Yoshio H, Tollin M, Gudmundsson GH, Lagercrantz H, Jornvall H, Marchini G, Agerberth B (2003) Antimicrobial polypeptides of human vernix caseosa and amniotic fluid: implications for newborn innate defense. Pediatr Res 53(2):211–216. doi:10.1203/01.PDR.0000047471.47777.B0
Acknowledgements
We thank Prof Maria Antonietta Tufano (Department of Experimental Medicine, Section of Microbiology and Clinical Microbiology, Second University of Naples) for sharing its scientific expertise with us and for valuable discussions.
Competing Interests
The authors declare that they have no competing interests.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Donnarumma, G. et al. (2015). β-Defensins: Work in Progress. In: Donelli, G. (eds) Advances in Microbiology, Infectious Diseases and Public Health. Advances in Experimental Medicine and Biology(), vol 901. Springer, Cham. https://doi.org/10.1007/5584_2015_5016
Download citation
DOI: https://doi.org/10.1007/5584_2015_5016
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-27934-3
Online ISBN: 978-3-319-27935-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)